Questions Left Unanswered Despite FDA holding hearings, and PhRMA issuing guidelines to help diminish controversial promotional activity, it remains
unclear what specific problem needs to be addressed in order to improve industry's use of direct-to-consumer marketing.
Lou Morris is president of Louis A. Morris & Associates, which specializes in regulatory research and consulting. Morris spent 23 years at FDA and is currently a member of FDA’s Drug Safety and Risk Management Advisory Committee. He can be reached at email@example.com or (631) 385-1172.
Articles by Lou Morris